Supplementary Table 4 from Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations
Authors:
- Kaushik VaradarajanKVKaushik Varadarajan
- Christian X. Cruz PicoCPChristian X. Cruz Pico
- Kurt W. EvansKEKurt W. Evans
- Maria Gabriela RasoMaria Gabriela Raso
- Yasmeen Qamar RizviYRYasmeen Qamar Rizvi
- Xiaofeng ZhengXZXiaofeng Zheng
- Dhruv ChachadDCDhruv Chachad
- Timothy P. DiPeriTDTimothy P. DiPeri
- Bailiang WangBWBailiang Wang
- Stephen M. ScottSSStephen M. Scott
- Ming ZhaoMZMing Zhao
- Argun AkcakanatAAArgun Akcakanat
Open Access
- 2 September 2025
- other
- Published by American Association for Cancer Research (AACR)